Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Bullboard (TSX:LABS)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
Comment by subaru1on Jun 20, 2024 10:57am

RE:Center for Disease Control (CDC U.S.) and avian bird flu

Sound as a good call, let see what is next with this acquisition.
33
Discussion
Post by subaru1on Jun 20, 2024 10:53am

For your info

.E.I. cannabis companies aim to move industry to next phase ‘It’s going to shift more like the craft beer industry’ Kevin Yarr · CBC News ·  Posted: Sep 19 ...more  
78
Post by pidukson Jun 20, 2024 10:24am

Center for Disease Control (CDC U.S.) and avian bird flu

Inhalers provide a rapid response to lung infections caused by avian bird flu to mitigate pneumonia in the lungs of humans exposed to avian bird flu.   The CDC has already contacted several ...more  
103
Discussion
Comment by Solid1on Jun 20, 2024 8:26am

RE:RE:Remidose

This acquisition is clearly aimed at the pharmaceutical market Aerosol has a much higher bioavailability than oils. In my opinion, a very clever acquisition at zero cost! But the big secret remains a ...more  
86
Discussion
Comment by Lemoyneon Jun 20, 2024 7:47am

RE:Remidose

Remains to be seen how Labs leverages this. But for now: This is non dilutive Is fully complementary with labs offerings, not competing with current brands and lines of product. No ...more  
78
Discussion
Comment by QContinuum1on Jun 20, 2024 7:14am

RE:Are you def? Read this sentence pls.

First things first, deaf and illiterate are two very different things.  For the record, I am neither. Secondly, this settlement (and like others) has nothing to do with LABS, for had it, they ...more  
68
Discussion
Post by QContinuum1on Jun 20, 2024 7:07am

Remidose

Pretty underwhelming release.  Remidose website looks like it was put together by a 12 year old and given that most likely people haven't ever heard a thing about them, they can't be ...more  
135
Discussion
Comment by mdjbrownon Jun 19, 2024 9:57pm

RE:Are you def? Read this sentence pls.

alleyesonme, just to throw a wrench into theories, there have been further developments regarding litigation settlement with defendants according to Jazz's Form Q10 filed for the quarterly period ...more  
75
Discussion
Post by pidukson Jun 19, 2024 5:55pm

Medipharm Labs formulation for generic Epidiolex

is NO WHERE near the same as JAZZ.   First of all JAZZ uses seasame oil to suspend the CBD which in itself can create problems and slow down absorption, therefore also in liquid form.   ...more  
88
Post by alleyesonmeon Jun 19, 2024 4:48pm

Are you def? Read this sentence pls.

  According to Jazz’s filings, in October 2023, it settled with Padagis US LLC and granted Padagis a license to manufacture, market, and sell its generic version of Epidiolex on a date that ...more  
105
Discussion
Comment by QContinuum1on Jun 19, 2024 2:31pm

RE:Quarterly call transcripts

They can state they are preparing for Epidiolex launch all they'd like, but facts are facts, the ANDA associated with that is going nowhere until the patent litigation is settled (positively ...more  
61
Discussion
Post by mdjbrownon Jun 19, 2024 1:44pm

Interesting developments from Sapient Therapeutics

and their oral capsule that could rival Epidiolex      https://businessofcannabis.com/ex-gw-pharma-bosses-lead-development-of-new-cbd-based-epilepsy-drug/
76
Post by mdjbrownon Jun 19, 2024 12:11pm

Quarterly call transcripts

If you have time to go back and read the quarterly call transcripts back to 2020, there is a lot of good info directly from the execs.   Q2, 2023 ‘If and when our pharmaceutical partner is ...more  
100
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities